Pharmacokinetics and pharmacodynamics of the novel Nrf2 activator omaveloxolone in primates
- 期刊名称Drug Design, Development and Therapy
- 作者Reisman, Scott A; Gahir, Sarabjit S; Lee, Chun-Yue I; Proksch, Joel W; Sakamoto, Mitsumasa; Ward, Keith W
- 电子ISSN1177-8881
- 文件大小1541.08KB
- 发表时间2019-04
- DOI10.2147/DDDT.S193889
- 页码1259-1270
Frailty syndrome: an overviewLeng, Sean; Chen, Xujiao; Mao, Genxiang · Clinical Interventions in Aging · 2014
The aging lungKovacs, Elizabeth; Lowery, Erin; Kuhlmann, Erica; Brubaker, Aleah · Clinical Interventions in Aging · 2013
ArrayMatsubara, Mariko; Tohara, Haruka; Hara, Koji; Shinozaki, Hiromichi; Yamazaki, Yasuhiro; Susa, Chiaki; Nakane, Ayako; Wakasugi, Yoko; Minakuchi, Shunsuke · Clinical Interventions in Aging · 2018
Hypernatremia in the geriatric populationTaffet, George; Shah, Maulin; Workeneh, Biruh · Clinical Interventions in Aging · 2014
Sarcopenic obesity and cognitive performanceTolea, Magdalena; Chrisphonte, Stephanie; Galvin, James · Clinical Interventions in Aging · 2018
Vitamin D and neurocognitive functionHolick, Michael; Schlogl, Mathias · Clinical Interventions in Aging · 2014
Dysmobility syndrome: current perspectivesHill, Keith; Farrier, Kaela; Russell, Melissa; Burton, Elissa · Clinical Interventions in Aging · 2017
Locomotive syndrome: clinical perspectivesIkemoto, Tatsunori; Arai, Young-Chang · Clinical Interventions in Aging · 2018